Pegfilgrastim (Neulasta) Biosimilars — Save Thousands
FDA-approved biosimilars for Pegfilgrastim (Neulasta) offer the same efficacy and safety at up to 55% lower cost — saving up to $2,475/year. Script Unlock connects you with pharmacies offering biosimilar pricing.
Reference product
$4,500
Pegfilgrastim (Neulasta)
Biosimilar price
from $2,025
save up to 55%
FDA-Approved Pegfilgrastim (Neulasta) Biosimilars
ZiextenzoFylnetraNyvepria
Are Biosimilars as Effective as Pegfilgrastim (Neulasta)?
- FDA requires biosimilars to have no clinically meaningful differences in safety or efficacy
- Same active ingredient, same mechanism of action
- Interchangeable biosimilars can be substituted without prescriber intervention
- Extensive clinical studies required before FDA approval